• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Key Treatment Considerations for Management of Atopic Dermatitis in Children
Dermatology
2 min
expert video

Key Treatment Considerations for Management of Atopic Dermatitis in Children

Epidemiology and Pathophysiology of AD in Children
Dermatology
2 min
expert video

Epidemiology and Pathophysiology of AD in Children

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
3 min
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Learn more about how dysregulated type 2 inflammation contributes to polymorphous lesions and dermal epidermal splitting in bullous pemphigoid
Dermatology
4 min
Infographic

Bullous Pemphigoid (BP) Pathophysiology Infographic

Type 2 Inflammation Within Skin Tissue in AD
Dermatology
4 min
expert video

Type 2 Inflammation Within Skin Tissue in AD

IL-4 Contributes to Systemic Type 2 Inflammation in AD
Dermatology
4 min
expert video

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case
Gastroenterology
8 min
interactivity

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Considerations for Disease Modification in AD
Dermatology
3 min
expert video

Considerations for Disease Modification in AD

ADVENT On Air - Dermatology
Dermatology
45 min
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
Dermatology
2 min
expert video

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid

Pathophysiology of Blister Formation in Bullous Pemphigoid
Dermatology
2 min
expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Etiology and Diagnosis of Bullous Pemphigoid
Dermatology
2 min
expert video

Etiology and Diagnosis of Bullous Pemphigoid

    1
    ...
    567
    ...
    9